Microglia

Biology and Polarization States#

Microglia derive from yolk sac progenitors during embryonic development and are maintained as a self-renewing population throughout life, distinct from peripheral monocytes and macrophages. In their resting (surveilling) state, they extend highly motile processes that continuously sample the brain parenchyma.

Upon activation, microglia adopt states along a polarization spectrum. M1 (pro-inflammatory): Produces TNF-alpha, IL-1beta, IL-6, ROS, and reactive nitrogen species (NO). Mediates neuronal damage through excitotoxicity and oxidative attack.

Activated by LPS, IFN-gamma, amyloid-beta, alpha-synuclein, and heavy metals.

M2 (anti-inflammatory/reparative): Produces IL-10, TGF-beta, and neurotrophic factors (BDNF, NGF). Promotes phagocytic clearance of debris and tissue repair.

The M1/M2 framework is a simplification—single-cell transcriptomics reveals a diverse landscape of microglial states—but it captures the essential tension: microglia can protect or destroy neurons depending on their activation state and chronicity.

Metal Activation of Microglia#

Heavy metals are potent and persistent microglial activators. Lead: Activates microglia via NF-kB signaling, increasing TNF-alpha and IL-6 production. Lead-activated microglia resist polarization back to the M2 state, creating chronic Neuroinflammation that outlasts the exposure.^{[1]Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseasesChin-Chan M, Navarro-Yepes J, Quintanilla-Vega B · 2015Open reference 1 ↓}

Mercury: Methylmercury activates the microglial NLRP3 inflammasome, driving IL-1beta release and neuronal apoptosis.

Manganese: Accumulates preferentially in the basal ganglia (same regions as PD pathology); activates microglia through mitochondrial ROS production and NF-kB signaling.^{[2]Heidari 2022 -- Outside In: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's DiseaseAmir Heidari, Nima Yazdanpanah, Nima Rezaei · 2022Open reference 2 ↓}

Cadmium: Activates microglia via TLR4 signaling; cadmium (Cd)-exposed microglia produce exaggerated inflammatory responses to subsequent LPS stimulation (priming effect).

Aluminum: Activates microglia and promotes amyloid-beta aggregation. aluminum (Al)-activated microglia show impaired phagocytic clearance of amyloid, worsening plaque burden.^{[3]Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer's Disease: A Review of Recent Evidence from Mechanistic StudiesGiasuddin Ahmed, Md. Shiblur Rahaman, Enrique Perez et al. · 2025Open reference 3 ↓}

Iron: Excess iron in microglia generates ROS via Fenton chemistry and promotes the pro-inflammatory M1 phenotype. Iron-loaded microglia around amyloid plaques amplify oxidative damage to surrounding neurons.^{[4]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 4 ↓}

A critical feature of metal-activated microglia is their resistance to phenotype switching: once pushed into a pro-inflammatory state by metals, microglia remain activated even after metal levels normalize, creating a self-perpetuating neuroinflammatory environment.^{[5]Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsGao C, Jiang J, Tan Y et al. · 2023Open reference 5 ↓}

TREM2: The Key Therapeutic Target#

TREM2 (triggering receptor expressed on myeloid cells 2) is a microglial surface receptor critical for phagocytic clearance and inflammatory regulation.

TREM2 variants (R47H) are associated with 2-4 fold increased Alzheimer's disease risk. TREM2 enables disease-associated microglia (DAM) to transition from homeostatic to phagocytic states. TREM2-dependent DAM limit tau seeding and amyloid-beta spreading around plaques.

Loss of TREM2 function impairs amyloid-beta phagocytosis and increases amyloid seeding. MgND (microglial neurodegenerative) state microglia hypersecrete extracellular vesicles containing phosphorylated tau.^{[5]Microglia in neurodegenerative diseases: mechanism and potential therapeutic targetsGao C, Jiang J, Tan Y et al. · 2023Open reference 5 ↓}